Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0001209191-23-056804

Chief Medical Officer acquired 88,822 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Nichols William Garrett Chief Medical Officer 2023-11-26 Grant or award +88,822 147,301 D
Loading xslF345X05/doc4.xml…